BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37099714)

  • 1. Mitochondria-Targeted Nanosystem Enhances Radio-Radiodynamic-Chemodynamic Therapy on Triple Negative Breast Cancer.
    Li J; You Z; Zhai S; Zhao J; Lu K
    ACS Appl Mater Interfaces; 2023 May; 15(18):21941-21952. PubMed ID: 37099714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide-mediated regulation of mitochondrial protective autophagy for enhanced chemodynamic therapy based on mesoporous Mo-doped Cu
    Zhou Z; Gao Z; Chen W; Wang X; Chen Z; Zheng Z; Chen Q; Tan M; Liu D; Zhang Y; Hou Z
    Acta Biomater; 2022 Oct; 151():600-612. PubMed ID: 35953045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable BiOCl platform for oxidative stress injury-enhanced chemodynamic/radiation therapy of hypoxic tumors.
    Liu Y; Zhang J; Du J; Song K; Liu J; Wang X; Li B; Ouyang R; Miao Y; Sun Y; Li Y
    Acta Biomater; 2021 Jul; 129():280-292. PubMed ID: 34033970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key Modulation of ROS and HSP for Effective Therapy Against Hypoxic Tumor with Multifunctional Nanosystem.
    Ma B; Zhao Y; Liu X; Huo M; Wang J; Ma J; Zhang Y; Qin C
    Int J Nanomedicine; 2023; 18():6829-6846. PubMed ID: 38026539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted co-delivery of a photosensitizer and an antisense oligonucleotide based on an activatable hyaluronic acid nanosystem with endogenous oxygen generation for enhanced photodynamic therapy of hypoxic tumors.
    Wu Y; Ding L; Zheng C; Li H; Wu M; Sun Y; Liu X; Zhang X; Zeng Y
    Acta Biomater; 2022 Nov; 153():419-430. PubMed ID: 36115655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose X-ray radiodynamic therapy solely based on gold nanoclusters for efficient treatment of deep hypoxic solid tumors combined with enhanced antitumor immune response.
    Zhu S; Yan F; Yang L; Li B; Xue R; Yu W; Wang Y; Huang L; Wang L; Han R; Jiang Y
    Theranostics; 2023; 13(3):1042-1058. PubMed ID: 36793856
    [No Abstract]   [Full Text] [Related]  

  • 7. 5‑aminiolevulinic acid induces a radiodynamic effect with enhanced delayed reactive oxygen species production under hypoxic conditions in lymphoma cells: An
    Suzuki K; Yamamoto J; Toh K; Miyaoka R
    Exp Ther Med; 2023 Jul; 26(1):360. PubMed ID: 37324514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tumor pH-responsive autocatalytic nanoreactor as a H
    Liu F; He T; Gong S; Shen M; Ma S; Huang X; Li L; Wang L; Wu Q; Gong C
    Acta Biomater; 2022 Dec; 154():510-522. PubMed ID: 36241016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open-Source and Reduced-Expenditure Nanosystem with ROS Self-Amplification and Glutathione Depletion for Simultaneous Augmented Chemodynamic/Photodynamic Therapy.
    Chen M; Zhao S; Zhu J; Feng E; Lv F; Chen W; Lv S; Wu Y; Peng X; Song F
    ACS Appl Mater Interfaces; 2022 May; 14(18):20682-20692. PubMed ID: 35500204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomimetic nanoplatform with H
    Fu LH; Wu XY; He J; Qi C; Lin J; Huang P
    Acta Biomater; 2023 May; 162():44-56. PubMed ID: 36934891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cascade-Enhanced Catalytic Nanocomposite with Glutathione Depletion and Respiration Inhibition for Effective Starving-Chemodynamic Therapy Against Hypoxic Tumor.
    Zhang Y; Hu H; Deng X; Song Q; Xing X; Liu W; Zhang Y
    Int J Nanomedicine; 2022; 17():5491-5510. PubMed ID: 36438608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced cancer therapy by hypoxia-responsive copper metal-organic frameworks nanosystem.
    Zhang K; Meng X; Yang Z; Dong H; Zhang X
    Biomaterials; 2020 Nov; 258():120278. PubMed ID: 32781328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albumin-assembled copper-bismuth bimetallic sulfide bioactive nanosphere as an amplifier of oxidative stress for enhanced radio-chemodynamic combination therapy.
    Tao W; Tuo Z; Wu F; Mu K; Xu C; Shi Y; Sun Z; Wang Y; Li Y; Zhong Z; Zhou L; Wang J; Liu J; Du Y; Zhang S
    Regen Biomater; 2022; 9():rbac045. PubMed ID: 35855112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A self-amplified nanocatalytic system for achieving "1 + 1 + 1 > 3" chemodynamic therapy on triple negative breast cancer.
    Zhou L; Chen J; Sun Y; Chai K; Zhu Z; Wang C; Chen M; Han W; Hu X; Li R; Yao T; Li H; Dong C; Shi S
    J Nanobiotechnology; 2021 Sep; 19(1):261. PubMed ID: 34481495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radio-resistance of hypoxic tumors: exploring the effects of oxygen and x-ray radiation on non-small lung cancer cell lines.
    Hanley R; Pagliari F; Garcia-Calderón D; Fernandes Guerreiro J; Genard G; Jansen J; Nisticò C; Marafioti MG; Tirinato L; Seco J
    Radiat Oncol; 2023 May; 18(1):81. PubMed ID: 37173741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoscale metal-organic frameworks for mitochondria-targeted radiotherapy-radiodynamic therapy.
    Ni K; Lan G; Veroneau SS; Duan X; Song Y; Lin W
    Nat Commun; 2018 Oct; 9(1):4321. PubMed ID: 30333489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable Biomimic Copper/Manganese Silicate Nanospheres for Chemodynamic/Photodynamic Synergistic Therapy with Simultaneous Glutathione Depletion and Hypoxia Relief.
    Liu C; Wang D; Zhang S; Cheng Y; Yang F; Xing Y; Xu T; Dong H; Zhang X
    ACS Nano; 2019 Apr; 13(4):4267-4277. PubMed ID: 30901515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygen-Evolving Radiotherapy-Radiodynamic Therapy Synergized with NO Gas Therapy by Cerium-Based Rare-Earth Metal-Porphyrin Framework.
    Lin J; He Y; Li Y; Chen J; Liu X
    Small; 2024 May; ():e2310957. PubMed ID: 38698608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocatalytic oncotherapy nanosystem with glucose depletion for the cascade amplification of hypoxia-activated chemotherapy and H
    Hu Y; Bai S; Fan X; Zhou F; Chen B; Tan S; Xu H; Pan A; Liang S; He Y
    Biomater Sci; 2022 May; 10(9):2358-2369. PubMed ID: 35383789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.